Close Menu

Thomas Mailund is "miffed." The cause: not very nice reviews from a journal where he submitted two papers. Not only were they not nice, they were short, not constructive, and the editorial staff hasn't made a decision yet on whether to accept the paper. Even if he resubmits it with changes, he still might not please them.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.